Register entry
CHONGQING HUAPONT SHENGCHEM PHARM. CO., LTD.
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 10
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
1010 active NDC listings: 10 bulk ingredient. By marketing category: BULK INGREDIENT 8, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 2.
| Dosage form | NDCs |
|---|---|
| powder | 10 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| chongqing huapont shengchem pharm. co., ltd. | 8 |
| chongqing huapont shengchem pharm. co., inc. | 2 |
Catalogue
Marketed products
10| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | CALCIPOTRIENE ANHYDROUS | powder | 48943-0022BULK INGREDIENT |
| - | CALCIPOTRIENE ANHYDROUS | powder | 48943-0026BULK INGREDIENT |
| - | CALCIPOTRIENE ANHYDROUS | powder | 48943-0032BULK INGREDIENT |
| - | CALCIPOTRIENE MONOHYDRATE | powder | 48943-0023BULK INGREDIENT |
| - | CALCIPOTRIENE MONOHYDRATE | powder | 48943-0030BULK INGREDIENT |
| - | ISONIAZID | powder | 48943-0039BULK INGREDIENT |
| - | Moxifloxacin Hydrochloride | powder | 48943-0024BULK INGREDIENT |
| - | TAZAROTENE | powder | 48943-0027BULK INGREDIENT |
| - | Tazarotene | powder | 48943-0036BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Tretinoin | powder | 48943-0016BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
Enquiry
Common questions
- Is CHONGQING HUAPONT SHENGCHEM PHARM. CO., LTD. FDA approved?
- CHONGQING HUAPONT SHENGCHEM PHARM. CO., LTD. holds no registered establishment of its own; 10 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does CHONGQING HUAPONT SHENGCHEM PHARM. CO., LTD. make?
- 10 products are listed under CHONGQING HUAPONT SHENGCHEM PHARM. CO., LTD. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.